Strategic Direction
- To identify shortcomings in technology and knowledge in developing countries with a goal to improve training programs and cooperation;
- To inspire trainees from chemistry, physics, biology, and clinical medicine to pursue a career in imaging-related
therapeutics discovery; - To increase the number of post-doctoral fellows and students that represent underserved populations in
molecular imaging that make a successful transition to academic faculty and attractive industry positions; - To increase the number of top scientists from the physical and imaging sciences and clinical medicine who
specialize in molecular imaging-enabled therapy; - To developing global research collaborations and mentorship models relevant to molecular imaging and therapy;
- To formally represent WMIS as part of complementary/related groups, such as the Coalition of PET Drug
Manufacturers - To constitute an Advisory Group made up of successful scientists who would be willing to serve as ambassadors
to- and collaboration partners of- researchers in development countries - To nominate molecular imaging scientists to serve on relevant journal editorial boards that publish molecular
imaging-enabled therapeutics discovery - To collaborate with other WMIS committees/groups that have the shared goal to advance molecular imaging
sciences in diagnosis and treatment of disease - To establish a subgroup of early-professionals (graduate students and postdocs) interested in translating new
molecular imaging-enabled therapies who will benefit from networking opportunities, mentoring programs,
educational workshops and related programming.